Construction
Compare Stocks
5 / 10Stock Comparison
AWI vs JCI vs CARR vs HON vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Construction
Construction
Conglomerates
Industrial - Machinery
AWI vs JCI vs CARR vs HON vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Construction | Construction | Construction | Conglomerates | Industrial - Machinery |
| Market Cap | $7.05B | $85.23B | $56.07B | $136.91B | $79.02B |
| Revenue (TTM) | $1.65B | $24.43B | $21.87B | $36.76B | $18.32B |
| Net Income (TTM) | $306M | $3.53B | $1.32B | $4.10B | $2.44B |
| Gross Margin | 40.3% | 36.6% | 24.8% | 36.9% | 52.7% |
| Operating Margin | 27.5% | 13.6% | 8.1% | 14.9% | 19.8% |
| Forward P/E | 19.9x | 29.4x | 24.2x | 20.5x | 21.7x |
| Total Debt | $532M | $11.19B | $12.67B | $34.58B | $13.76B |
| Cash & Equiv. | $113M | $379M | $1.55B | $12.49B | $1.54B |
AWI vs JCI vs CARR vs HON vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Armstrong World Ind… (AWI) | 100 | 219.0 | +119.0% |
| Johnson Controls In… (JCI) | 100 | 443.3 | +343.3% |
| Carrier Global Corp… (CARR) | 100 | 327.8 | +227.8% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AWI vs JCI vs CARR vs HON vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AWI carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 12.1%, EPS growth 17.6%, 3Y rev CAGR 9.5%
- Lower volatility, beta 0.82, Low D/E 59.0%, current ratio 1.46x
- 12.1% revenue growth vs CARR's -3.3%
- Lower P/E (19.9x vs 21.7x)
JCI ranks third and is worth considering specifically for long-term compounding and valuation efficiency.
- 343.3% 10Y total return vs CARR's 493.6%
- PEG 1.15 vs HON's 11.18
- +56.9% vs CARR's -2.8%
CARR lags the leaders in this set but could rank higher in a more targeted comparison.
HON is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Beta 0.74, yield 2.1%, current ratio 1.32x
- Beta 0.74 vs EMR's 1.52
- 2.1% yield, 15-year raise streak, vs EMR's 1.5%
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.1% revenue growth vs CARR's -3.3% | |
| Value | Lower P/E (19.9x vs 21.7x) | |
| Quality / Margins | 18.6% margin vs CARR's 6.0% | |
| Stability / Safety | Beta 0.74 vs EMR's 1.52 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +56.9% vs CARR's -2.8% | |
| Efficiency (ROA) | 16.0% ROA vs CARR's 3.5%, ROIC 24.9% vs 6.7% |
AWI vs JCI vs CARR vs HON vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AWI vs JCI vs CARR vs HON vs EMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AWI leads in 2 of 6 categories
JCI leads 0 • CARR leads 0 • HON leads 0 • EMR leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — AWI and JCI and EMR each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 22.3x AWI's $1.6B. AWI is the more profitable business, keeping 18.6% of every revenue dollar as net income compared to CARR's 6.0%. On growth, JCI holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.6B | $24.4B | $21.9B | $36.8B | $18.3B |
| EBITDAEarnings before interest/tax | $603M | $3.9B | $3.1B | $6.5B | $4.7B |
| Net IncomeAfter-tax profit | $306M | $3.5B | $1.3B | $4.1B | $2.4B |
| Free Cash FlowCash after capex | $247M | $1.4B | $1.7B | $4.2B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +40.3% | +36.6% | +24.8% | +36.9% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +27.5% | +13.6% | +8.1% | +14.9% | +19.8% |
| Net MarginNet income ÷ Revenue | +18.6% | +14.5% | +6.0% | +11.2% | +13.3% |
| FCF MarginFCF ÷ Revenue | +15.0% | +5.7% | +7.6% | +11.4% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.1% | +8.2% | +2.4% | -6.9% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -1.9% | +38.9% | -40.4% | -41.9% | +28.2% |
Valuation Metrics
AWI leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 23.3x trailing earnings, AWI trades at a 56% valuation discount to JCI's 52.9x P/E. Adjusting for growth (PEG ratio), JCI offers better value at 2.06x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7.0B | $85.2B | $56.1B | $136.9B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $7.5B | $96.0B | $67.2B | $159.0B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | 23.32x | 52.95x | 39.48x | 29.36x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.87x | 29.38x | 24.18x | 20.52x | 21.71x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.06x | — | 15.99x | 7.73x |
| EV / EBITDAEnterprise value multiple | 17.23x | 26.01x | 21.71x | 19.99x | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 4.35x | 3.61x | 2.58x | 3.66x | 4.39x |
| Price / BookPrice ÷ Book value/share | 7.99x | 7.03x | 4.02x | 9.00x | 3.94x |
| Price / FCFMarket cap ÷ FCF | 28.63x | 88.32x | 33.04x | 25.39x | 29.63x |
Profitability & Efficiency
AWI leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
AWI delivers a 34.8% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $9 for CARR. AWI carries lower financial leverage with a 0.59x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), AWI scores 9/9 vs CARR's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +34.8% | +24.9% | +9.1% | +23.1% | +12.1% |
| ROA (TTM)Return on assets | +16.0% | +9.0% | +3.5% | +5.3% | +5.8% |
| ROICReturn on invested capital | +24.9% | +8.5% | +6.7% | +12.6% | +8.2% |
| ROCEReturn on capital employed | +26.5% | +9.8% | +7.2% | +12.6% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 6 | 4 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.59x | 0.86x | 0.90x | 2.24x | 0.68x |
| Net DebtTotal debt minus cash | $419M | $10.8B | $11.1B | $22.1B | $12.2B |
| Cash & Equiv.Liquid assets | $113M | $379M | $1.6B | $12.5B | $1.5B |
| Total DebtShort + long-term debt | $532M | $11.2B | $12.7B | $34.6B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 13.31x | 18.41x | 5.76x | 3.92x | 6.46x |
Total Returns (Dividends Reinvested)
Evenly matched — AWI and JCI and CARR each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JCI five years ago would be worth $22,286 today (with dividends reinvested), compared to $10,326 for HON. Over the past 12 months, JCI leads with a +56.9% total return vs CARR's -2.8%. The 3-year compound annual growth rate (CAGR) favors AWI at 36.0% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.0% | +14.2% | +26.3% | +10.9% | +4.3% |
| 1-Year ReturnPast 12 months | +11.5% | +56.9% | -2.8% | +2.8% | +30.4% |
| 3-Year ReturnCumulative with dividends | +151.8% | +127.9% | +63.4% | +16.2% | +75.9% |
| 5-Year ReturnCumulative with dividends | +63.0% | +122.9% | +58.0% | +3.3% | +59.5% |
| 10-Year ReturnCumulative with dividends | +330.4% | +343.3% | +493.6% | +135.1% | +206.6% |
| CAGR (3Y)Annualised 3-year return | +36.0% | +31.6% | +17.8% | +5.1% | +20.7% |
Risk & Volatility
Evenly matched — JCI and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JCI currently trades 94.5% from its 52-week high vs AWI's 80.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.82x | 0.97x | 1.19x | 0.74x | 1.52x |
| 52-Week HighHighest price in past year | $206.08 | $147.32 | $81.09 | $248.18 | $165.15 |
| 52-Week LowLowest price in past year | $148.25 | $87.77 | $50.24 | $186.76 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +80.1% | +94.5% | +82.8% | +87.1% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 41.3 | 56.2 | 64.2 | 45.1 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 494K | 3.3M | 6.6M | 3.7M | 2.8M |
Analyst Outlook
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AWI as "Buy", JCI as "Buy", CARR as "Buy", HON as "Buy", EMR as "Buy". Consensus price targets imply 19.6% upside for AWI (target: $198) vs -0.9% for JCI (target: $138). For income investors, HON offers the higher dividend yield at 2.14% vs AWI's 0.77%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $197.50 | $138.00 | $67.50 | $243.83 | $161.92 |
| # AnalystsCovering analysts | 26 | 45 | 26 | 28 | 41 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | +1.1% | +1.4% | +2.1% | +1.5% |
| Dividend StreakConsecutive years of raises | 8 | 5 | 6 | 15 | 37 |
| Dividend / ShareAnnual DPS | $1.27 | $1.49 | $0.91 | $4.63 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.8% | +7.0% | +5.2% | +2.8% | +1.6% |
AWI leads in 2 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 4 categories are tied.
AWI vs JCI vs CARR vs HON vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AWI or JCI or CARR or HON or EMR a better buy right now?
For growth investors, Armstrong World Industries, Inc.
(AWI) is the stronger pick with 12. 1% revenue growth year-over-year, versus -3. 3% for Carrier Global Corporation (CARR). Armstrong World Industries, Inc. (AWI) offers the better valuation at 23. 3x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate Armstrong World Industries, Inc. (AWI) a "Buy" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AWI or JCI or CARR or HON or EMR?
On trailing P/E, Armstrong World Industries, Inc.
(AWI) is the cheapest at 23. 3x versus Johnson Controls International plc at 52. 9x. On forward P/E, Armstrong World Industries, Inc. is actually cheaper at 19. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Johnson Controls International plc wins at 1. 15x versus Honeywell International Inc. 's 11. 18x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AWI or JCI or CARR or HON or EMR?
Over the past 5 years, Johnson Controls International plc (JCI) delivered a total return of +122.
9%, compared to +3. 3% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: CARR returned +493. 6% versus HON's +135. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AWI or JCI or CARR or HON or EMR?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 105% more volatile than HON relative to the S&P 500. On balance sheet safety, Armstrong World Industries, Inc. (AWI) carries a lower debt/equity ratio of 59% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AWI or JCI or CARR or HON or EMR?
By revenue growth (latest reported year), Armstrong World Industries, Inc.
(AWI) is pulling ahead at 12. 1% versus -3. 3% for Carrier Global Corporation (CARR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -72. 4% for Carrier Global Corporation. Over a 3-year CAGR, AWI leads at 9. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AWI or JCI or CARR or HON or EMR?
Armstrong World Industries, Inc.
(AWI) is the more profitable company, earning 19. 0% net margin versus 6. 9% for Carrier Global Corporation — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AWI leads at 26. 6% versus 9. 9% for CARR. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AWI or JCI or CARR or HON or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Johnson Controls International plc (JCI) is the more undervalued stock at a PEG of 1. 15x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Armstrong World Industries, Inc. (AWI) trades at 19. 9x forward P/E versus 29. 4x for Johnson Controls International plc — 9. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AWI: 19. 6% to $197. 50.
08Which pays a better dividend — AWI or JCI or CARR or HON or EMR?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 8% for Armstrong World Industries, Inc. (AWI).
09Is AWI or JCI or CARR or HON or EMR better for a retirement portfolio?
For long-horizon retirement investors, Armstrong World Industries, Inc.
(AWI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 0. 8% yield, +330. 4% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AWI: +330. 4%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AWI and JCI and CARR and HON and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.